Amplitude Healthcare Acquisition Corporation

Status: Deal Closed
U=S+W/2 W=S@11.5
IPO Proceeds, $M $100.00M
IPO Date Nov 20, 2019
CEO Bala Venkataraman
Left Lead BMO Capital Markets
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare
IPO Geography Global
Target Company Jasper Therapeutics
Deal Announced May 6, 2021
Deal Size, $M $290.00M
Deal Sector Healthcare
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Sep 22, 2021
Amendment Vote TBD
Closing Date Sep 24, 2021
Formerly AMHC JSPR JSPRW

Sign up for Free Trial

No credit card required

Sign in for more on Amplitude Healthcare Acquisition Corporation:

  • Structure and cap table
  • 7 directors & officers
  • 22 filings and events
  • 2 underwriters
  • 6 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Howard Hoffen 55 Chairman
Bala Venkataraman 52 Chief Executive Officer and Director
Kenneth Clifford 63 Chief Financial Officer
Fred Eshelman 71 Director
Ernest Mario 81 Director
Peter Dolan 63 Director
Glenn Reicin 55 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
BMO Capital Markets Joint BR 5,500,000 units
SVB Securities Joint BR 4,500,000
10,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 22 filings.

Shareholders

Sign in to view shareholders 13F filing data.